IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
View Top Employees from IM Therapeutics| Website | https://www.imtherapeutics.com/ |
| Revenue | $5 million |
| Funding | $10 million |
| Employees | 5 (5 on RocketReach) |
| Founded | 2015 |
| Address | 299 Washington St Suite A, Woburn, Massachusetts 01801, US |
| Phone | (303) 544-2104 |
| Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Science and Engineering |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular IM Therapeutics employee's phone or email?
IM Therapeutics Questions
The IM Therapeutics annual revenue was $5 million in 2024.
5 people are employed at IM Therapeutics.
IM Therapeutics is based in Woburn, Massachusetts.
The NAICS codes for IM Therapeutics are [3254, 325, 32541, 32].
The SIC codes for IM Therapeutics are [283, 28].
Top IM Therapeutics Employees
-
14
-
ViewDavid Alleva
Sr. VP, Research & Development at IM Therapeutics
Ipswich, Massachusetts, United States13 -
25+
-
ViewKaitlyn Sullivan
CMC and Regulatory Senior Manager at IM Therapeutics
Cleveland, Ohio, United States2
Related Companies
